Featured Research

from universities, journals, and other organizations

Loss of enzyme reduces neural activity in Angelman syndrome

Date:
March 10, 2010
Source:
Harvard Medical School
Summary:
Angelman syndrome (AS) is a debilitating neurological disorder characterized by mental retardation and a high frequency of autism. Researchers have now found that the gene mutation underlying AS appears to affect the ability of neurons to communicate and to properly develop during the first few years of life, a time when brain activity is "rewired" by external stimuli.

Angelman Syndrome is a rare but serious genetic disorder that causes a constellation of developmental problems in affected children, including mental retardation, lack of speech, and in some cases, autism. Over a decade ago, researchers found that AS was caused by mutation in a single gene, but no one had been able to explain how this defect resulted in the debilitating neurological symptoms of the disease.

Related Articles


New work from Michael Greenberg, chair of the department of neurobiology at Harvard Medical School (HMS), provides insight into the mystery by showing that the lost enzyme, Ube3A, interacts with a key neuronal protein in order to control how environmental input shapes synaptic connections. In other words, loss of Ube3A interferes with the brain's ability to use environmental experience to fine-tune neuronal circuits, which could explain the devastating developmental deficits that occur in AS. This suggests new targets for treating Angelman syndrome. Currently, doctors can manage some AS symptoms, but there is no treatment for the core features.

What's more, the Ube3A gene is also mutated in some cases of autism, raising the possibility that these findings may also explain some of the problems that occur in autism spectrum disorders, which are 100 times more common than AS.

"With this work, we've gone from a place where we could only imagine how Ube3A might work, to being able to think about possibilities for therapeutic intervention in a disorder where until very recently there was little that could be done," says Greenberg, Nathan Marsh Pusey professor of neurobiology at HMS.

These findings are published in the March 5 issue of Cell.

During the first few years of life, brain activity is "rewired" by external stimuli . This tweaking of neuronal connections is critical to establish normal neurological function, and is thought to go awry in a number of developmental disorders that lead to mental retardation or other cognitive problems. The new work suggests that Ube3A is a key regulator in this process, and ties the loss of Ube3A to a specific change in synaptic function.

Under normal conditions, the Ube3A enzyme tags cellular proteins for destruction. Co-ead author Paul Greer, a postdoctoral fellow in Greenberg's lab identified the synaptic protein Arc as one of Ube3A's targets. Arc's primary function is to decrease neuronal signaling. However, with a mutated Ube3A, Arc accumulates to higher than normal levels, which causes an abnormal lowering of neuronal signaling, leading to impaired neuronal communication and synaptic development.

The Arc connection has revealed surprising links to other disorders, Greenberg says. In Fragile X syndrome, a major form of inherited mental retardation, neurons also have an over-abundance of Arc protein. Although the excess Arc occurs through a different mechanism independent of Ube3A, the two diseases seem to converge on a common synaptic defect. That means new treatments now under study for Fragile X may someday be useful for Angelman Syndrome, Greenberg says.

The work may also suggest additional therapeutic targets for AS. As part of the study, the researchers identified several proteins regulated by Ube3A in addition to Arc, some of which might be involved in creating the complex features of AS. "It could be that affecting Arc levels may be useful for some of the symptoms of AS, while modulating other targets will be useful for others," Greer says. "We are hoping to identify many substrates upon which Ube3a is acting, and one can imagine doing targeted therapeutics on several of them."

This research was funded by the National Science Foundation, National Institutes of Health, Angelman Syndrome Foundation.


Story Source:

The above story is based on materials provided by Harvard Medical School. The original article was written by Pat McCaffrey. Note: Materials may be edited for content and length.


Journal Reference:

  1. Paul L. Greer, Rikinari Hanayama, Brenda L. Bloodgood, Alan R. Mardinly, David M. Lipton, Steven W. Flavell, Tae-Kyung Kim, Eric C. Griffith, Zacharywaldon, Rene Maehr, Hidde L. Ploegh, Shoaib Chowdhury, Paul F. Worley, Judith Steen, Michael E. Greenberg. The Angelman Syndrome-associated ubiquitin ligase Ube3A regulates synapse development by ubiquitinating Arc. Cell, 2010: 140 (5): 608-610 DOI: 10.1016/j.cell.2010.01.026

Cite This Page:

Harvard Medical School. "Loss of enzyme reduces neural activity in Angelman syndrome." ScienceDaily. ScienceDaily, 10 March 2010. <www.sciencedaily.com/releases/2010/03/100304121538.htm>.
Harvard Medical School. (2010, March 10). Loss of enzyme reduces neural activity in Angelman syndrome. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2010/03/100304121538.htm
Harvard Medical School. "Loss of enzyme reduces neural activity in Angelman syndrome." ScienceDaily. www.sciencedaily.com/releases/2010/03/100304121538.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com
Madagascar Working to Contain Plague Outbreak

Madagascar Working to Contain Plague Outbreak

AFP (Nov. 24, 2014) — Madagascar said Monday it is trying to contain an outbreak of plague -- similar to the Black Death that swept Medieval Europe -- that has killed 40 people and is spreading to the capital Antananarivo. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Are Female Bosses More Likely To Be Depressed?

Are Female Bosses More Likely To Be Depressed?

Newsy (Nov. 24, 2014) — A new study links greater authority with increased depressive symptoms among women in the workplace. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins